01—History
Long-Term Debt History
Quarterly data from 10-Q and 10-K reports
- $0
QoQ changeLargest recent move−51.8%in Q3 FY17
2 older moves run past ±100% (largest +289.2%); point at, tap or drag across the bars to read one.
02—Ledger
Long-Term Debt, period by period
| Period | Value | Source | |
|---|---|---|---|
| Q4FY2018 | $0 | — | 10-K |
| Q3FY2018 | $0 | — | 10-Q |
| Q2FY2018 | $0 | −100.0% | 10-Q |
| Q1FY2018 | $113.3M | −40.1% | 10-Q |
| Q4FY2017 | $189.1M | −0.9% | 10-K |
| Q3FY2017 | $190.9M | −51.8% | 10-Q |
| Q2FY2017 | $396.1M | +1.9% | 10-Q |
| Q1FY2017 | $388.7M | −7.0% | 10-Q |
| Q4FY2016 | $417.9M | +10.7% | 10-K |
| Q3FY2016 | $377.4M | +1.7% | 10-Q |
| Q2FY2016 | $371.2M | +1.9% | 10-Q |
| Q1FY2016 | $364.4M | +40.6% | 10-Q |
| Q4FY2015 | $259.1M | +0.5% | 10-K |
| Q3FY2015 | $258.0M | +1.7% | 10-Q |
| Q2FY2015 | $253.7M | −25.7% | 10-Q |
| Q1FY2015 | $341.6M | +1.8% | 10-Q |
| Q4FY2014 | $335.5M | +1.8% | 10-K |
| Q3FY2014 | $329.5M | +1.8% | 10-Q |
| Q2FY2014 | $323.6M | +1.8% | 10-Q |
| Q1FY2014 | $318.0M | −1.4% | 10-Q |
| Q4FY2013 | $322.6M | +289.2% | 10-K |
| Q3FY2013 | $82.9M | −0.9% | 10-Q |
| Q2FY2013 | $83.7M | −0.9% | 10-Q |
| Q1FY2013 | $84.5M | −52.2% | 10-Q |
| Q4FY2012 | $176.6M | +105.9% | 10-K |
| Q3FY2012 | $85.8M | −0.9% | 10-Q |
| Q2FY2012 | $86.6M | −49.3% | 10-Q |
| Q4FY2011 | $170.7M | — | 10-K |
03—Questions
- Company
- Exelixis
- Ticker
- EXEL
- Sector
- Healthcare
- Industry
- Biological Products, (No Diagnostic Substances)